These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18377372)

  • 1. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Wilcken B
    J Paediatr Child Health; 2008 Apr; 44(4):232-3; author reply 233. PubMed ID: 18377372
    [No Abstract]   [Full Text] [Related]  

  • 2. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?
    Castellani C; Massie J
    Eur Respir J; 2014 Jan; 43(1):20-3. PubMed ID: 24381320
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of population screening for carriers of cystic fibrosis.
    Smith MJ
    J Public Health Med; 1992 Sep; 14(3):257-63. PubMed ID: 1419203
    [No Abstract]   [Full Text] [Related]  

  • 5. Carrier screening for cystic fibrosis.
    Dungan JS
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of 31 CFTR mutations by polymerase chain reaction/oligonucleotide ligation assay in a pilot screening of 4476 newborns for cystic fibrosis.
    Gasparini P; Arbustini E; Restagno G; Zelante L; Stanziale P; Gatta L; Sbaiz L; Sedita AM; Banchieri N; Sapone L; Fiorucci GC; Brinson E; Shulse E; Rappaport E; Fortina P
    J Med Screen; 1999; 6(2):67-9. PubMed ID: 10444722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic problems in cystic fibrosis - specific characteristics of a group of infants and young children diagnosed positive through neonatal screening, in whom cystic fibrosis had not been diagnosed.
    Woś H; Sankiewicz-Szkółka M; Więcek S; Kordys-Darmolińska B; Grzybowska-Chlebowczyk U; Kniażewska M
    Dev Period Med; 2015; 19(1):25-31. PubMed ID: 26003067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal screening for the cystic fibrosis main mutation delta F508 in Estonia.
    Klaassen T; Teder M; Viikmaa M; Metspalu A
    J Med Screen; 1998; 5(1):16-9. PubMed ID: 9575453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive screening program for cystic fibrosis.
    Zlotogora J; Israeli A
    Isr Med Assoc J; 2009 Sep; 11(9):555-7. PubMed ID: 19960851
    [No Abstract]   [Full Text] [Related]  

  • 10. Carrier screening for cystic fibrosis.
    Massie J
    Lancet; 2009 Sep; 374(9694):978. PubMed ID: 19766881
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Newborn screening for cystic fibrosis, a clinical geneticist perspective].
    Sanak M
    Przegl Lek; 2011; 68(1):14-6. PubMed ID: 21563437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
    Soultan ZN; Foster MM; Newman NB; Anbar RD
    J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis screening at the Greenville Hospital System.
    Dacus J; Mabie B; Gailey T; Rogers C; Likes C; Metcalf L
    J S C Med Assoc; 2006 Feb; 102(1):14-6. PubMed ID: 16704181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygote screening for cystic fibrosis.
    Brock DJ
    J Med Screen; 1994 Apr; 1(2):130-3; discussion 133-4. PubMed ID: 8790502
    [No Abstract]   [Full Text] [Related]  

  • 16. Parental understanding of newborn screening for cystic fibrosis after a negative sweat-test.
    Lang CW; McColley SA; Lester LA; Ross LF
    Pediatrics; 2011 Feb; 127(2):276-83. PubMed ID: 21220393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis screening strategies.
    Cuckle H
    Br J Hosp Med; 1993 Oct 6-19; 50(7):398-402. PubMed ID: 8261285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prenatal, neonatal and postnatal prevention in cystic fibrosis].
    Frézal J; Briard ML; Farriaux JP
    Bull Acad Natl Med; 1993 Mar; 177(3):405-11; discussion 412. PubMed ID: 8364746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening for cystic fibrosis: where are we now?
    Farrell PM; Fost N
    J Pediatr; 2002 Dec; 141(6):758-63. PubMed ID: 12461490
    [No Abstract]   [Full Text] [Related]  

  • 20. Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members.
    Maxwell SJ; Kyne G; Molster C; Barker NM; Ormsby J; O'Leary P
    Genet Test Mol Biomarkers; 2011 Mar; 15(3):159-64. PubMed ID: 21204697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.